Adherence to ESMO 2014 guidelines on bone-targeting agent (BTA) initiation for breast and prostate cancer patients: Real-world insights from practicing European physicians

Rider, A; Seesaghur, A; Lewis, K; Bluff, D; Marongiu, A; Demonty, G

ANNALS OF ONCOLOGY, 2019; 30 ():